Why is Astrazeneca Phar falling/rising?

As of 16-Jul, Astrazeneca Pharma India Ltd's stock is currently priced at 9,195.75, reflecting an increase of 16.9 points or 0.18%. The stock has shown a positive trend recently, gaining for the last two days with a total return of 0.27%. It reached an intraday high of Rs 9538, indicating strong performance today, and has outperformed its sector by 0.45%. Despite a slight decline of 1.09% over the past week, the stock has delivered impressive returns of 39.52% over the last year and 208.81% over the last three years. Positive factors contributing to this rise include high management efficiency, a low debt-to-equity ratio, and significant growth in net profit, which has led to very positive quarterly results. However, the stock faces challenges such as a high valuation compared to peers and a decrease in institutional investor participation.
In the broader market context, Astrazeneca Pharma's short-term performance has been slightly better than the benchmark, as the Sensex has also declined by 1.08% over the past week. While the stock has outperformed the benchmark over the last year and three years, it has underperformed in the last month, where it fell by 10.23% compared to the Sensex's increase of 1.02%. This indicates that while Astrazeneca Pharma has strong long-term growth potential, recent short-term fluctuations may be influenced by broader market trends and investor sentiment.